The Indian supplements market is anticipated to soar to nearly fifty-seven billion dollars by twenty thirty, driven by heightened consumer awareness and the prevalence of lifestyle diseases. Major consumer goods firms are rushing to acquire scientifically validated nutraceutical brands. The lenient regulations imposed by FSSAI have led to a surge in new brand entries. To guarantee safety, India requires a dedicated regulatory body alongside strict quality standards.